BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36763678)

  • 1. Distribution of problematic localized facial infantile haemangiomas and their response to propranolol: a retrospective cohort study.
    Chang L; Chen Q; Zhou L; Chang SJ; Gao W; Yu Z; Chen J; Li H; Qiu Y; Lin X
    Clin Exp Dermatol; 2023 Mar; 48(3):193-198. PubMed ID: 36763678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
    Phillips RJ; Lokmic Z; Crock CM; Penington A
    J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of infantile hemangioma after termination of propranolol treatment.
    Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
    Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
    Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
    Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for infantile haemangiomas of the skin.
    Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
    Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol Therapy for Problematic Infantile Hemangioma.
    Ng M; Knuth C; Weisbrod C; Murthy A
    Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review.
    Diociaiuti A; Carnevale C; Torres EB; Léauté-Labrèze C; Neri I; Rotunno R; Figà-Talamanca L; El Hachem M
    Acta Derm Venereol; 2020 Sep; 100(16):adv00255. PubMed ID: 32735025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
    Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
    Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
    Léauté-Labrèze C; Taïeb A
    Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review.
    Sun LM; Xu Y; Xu MN; Wang M; Su Y; Yuan SM
    Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110157. PubMed ID: 32544638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.